RxDoctor Payments Data

Bret Schipper, MD

Surgical Oncology · Hartford, CTNPI 1821296500

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,063 of the $14,782 with a category attached, or 88.4%. Medtronic accounts for 84.1% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $12,279, more than ten times the $117 reported in 2019. Among surgical oncology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,782in general payments, 2019–2025

Across 41 payments — averaging $360.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$12K
  • Baxter Healthcare$1K
  • Intuitive Surgical$491
  • Johnson & Johnson$156
  • Olympus America Inc.$112
  • Abbott$85
  • plus $192 from 6 others
$48,414in research payments, 2019–2025

Across 41 payments — averaging $1180.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$43K
  • Covidien LP$6K

What the payments were for

  • Consulting fees$13,06388%
  • Travel & lodging$4463%
  • Food & beverage$8236%
  • Education$4503%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,782 in reported general payments places this provider in the 90th percentile of 30 surgical oncology providers in Connecticut.

See all surgical oncology providers in Connecticut

Medicare billing

Part B allowed, 2024
$39,188
Medicare patients
66
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase15$52,624
Pantoprazole Sodium15$273

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →